This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Choosing between equal and cap weight depends on goals and risk tolerance. This quick guide compares the two for retirement suitability.
24,468 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
In the first half, AMD and Intel outpaced Nvidia as investors rotated into laggards. This article breaks down what ha...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
A dramatic insider move at Apogee comes after a steep stock rise. This article breaks down the possible meanings, ris...
Cathie Wood goes selling has people watching Ark Invest closely. This article breaks down three key trims, the reason...
A notable stake in Patterson-UTI Energy raises questions about a possible oil-service rebound. This article dives int...
A notable stake reduction by pacific ridge capital trims its NWPX position, signaling a shift in exposure. This guide...
On a day when market indexes drift lower, a single retailer can move the needle while tech breakthroughs push a diffe...
Imagine owning stocks that pay you reliably for decades. This guide shows how to find the best dividend stocks hold a...
Leveraged ETFs like TQQQ and QLD promise amplified Nasdaq-100 exposure, but they come with unique risks and timing re...
Gold ETFs come in two main flavors: direct bullion exposure and mining stock ownership. This guide compares AAAU and ...
Seeking reliable income you can count on for decades? This guide highlights two blue-chip picks—Coca-Cola and Procter...